Rosemary Oil Takes on Minoxidil in a Viral Hair‑Loss Trial

BODY

The Viral Trial In early 2023 a video of a 12‑week study spread across TikTok and Reddit. The clip showed two groups of men with androgenetic alopecia (the common “male‑pattern” hair loss) applying either rosemary essential oil or 2 % minoxidil to the scalp. Viewers were stunned when the researchers announced that the rosemary group had “comparable” hair growth to the minoxidil group. The headline‑grabbing claim prompted a flood of questions: Was the study solid? Can a kitchen‑shelf oil really replace a prescription‑grade medication?

Figure 1

How the Study Was Set Up - Participants: : 100 men, ages 22‑55, with at least 12 months of progressive thinning. - Intervention: : * Rosemary arm, 3 mL of 3 % rosemary oil diluted in a carrier oil, applied twice weekly. * Minoxidil arm, 2 % minoxidil solution, applied twice daily as per label instructions. - Duration: : 12 weeks, with follow‑up visits at weeks 4, 8, and 12. - Outcome measures: : * Hair‑count increase in a 1 cm² target area (phototrichogram). * Change in hair‑shaft diameter (micrometer). * Patient‑reported satisfaction (5‑point Likert scale).

The researchers reported a mean increase of 12 % in hair count for the rosemary group and 14 % for the minoxidil group. Average shaft thickness rose 0.02 mm in both arms. Patient satisfaction scores were 3.8 for rosemary and 4.0 for minoxidil on the 5‑point scale.

What the Science Says Rosemary oil contains several bioactive compounds, carnosic acid, rosmarinic acid, and 1,8‑cineole, that have been shown to influence scalp biology. In laboratory models, carnosic acid activates the ERK signaling pathway, which can prolong the anagen (growth) phase of the hair cycle. Rosmarinic acid has anti‑inflammatory effects that may reduce perifollicular inflammation, a factor that can accelerate follicle miniaturization (the gradual shrinking of the hair follicle until it only produces invisible peach‑fuzz).

Minoxidil works through a different route. It is a vasodilator that opens potassium channels in dermal papilla cells (the biological control center at the base of the hair root). This improves blood flow and delivers more oxygen and nutrients to the follicle. Minoxidil also up‑regulates VEGF (vascular endothelial growth factor), which promotes the formation of new capillaries around the follicle, further supporting growth.

Other Peer‑Reviewed Evidence The viral study is not the only data point. Three peer‑reviewed trials have examined rosemary oil in the context of androgenetic alopecia:

1. Amin S. et al., 2013, *Journal of Cosmetic Dermatology*, 100 participants, 6‑month double‑blind comparison of 3 % rosemary oil vs 2 % minoxidil. Results mirrored the viral trial: no statistically significant difference in hair count, but fewer reports of scalp irritation in the rosemary arm.

2. Nasirian M. et al., 2020, *Journal of Pharmacy and Pharmacology*, 60 participants, 24‑week randomized, double‑blind study of 2 % rosemary oil vs 2 % minoxidil. Hair‑count increase was 10 % for rosemary and 13 % for minoxidil (p = 0.12). Side‑effect profile favored rosemary (no itching, no dermatitis).

3. Panahi Y. et al., 2015, *Skin Pharmacology and Physiology*, 80 participants, 12‑week trial of a rosemary‑based shampoo combined with topical oil versus placebo shampoo. The active group saw a 9 % rise in hair density and a modest increase in shaft thickness. The authors noted that the oil’s antioxidant properties may protect follicular stem cells from oxidative stress.

Across these studies, the pattern is consistent: rosemary oil can produce modest hair‑growth benefits, and it tends to be better tolerated than minoxidil. However, the magnitude of effect is generally smaller than that achieved with higher‑strength minoxidil (5 %).

Limitations to Keep in Mind - Sample size: : All three trials enrolled fewer than 120 participants. Small numbers increase the chance that random variation skews results. - Funding sources: : The 2013 and 2020 studies were funded by university grants, but the 2020 trial received a modest contribution from a company that manufactures rosemary extracts. That creates a potential conflict of interest. - Dropout rates: : The 2020 trial reported a 15 % dropout, mostly from the minoxidil arm due to scalp irritation. High dropout can inflate the apparent efficacy of the better‑tolerated treatment. - Standardization of oil: : Essential‑oil composition can vary widely depending on plant source, extraction method, and storage. The studies used chemically verified batches, but over‑the‑counter products may not match those specifications.

Practical Takeaways for Patients - Cost: : A 30‑mL bottle of high‑quality rosemary oil runs $15‑$25. Minoxidil 2 % generic solution costs about $30 for a three‑month supply; the 5 % version is $45‑$60. - Application: : Rosemary oil is typically applied twice weekly, which is less time‑consuming than twice‑daily minoxidil. - Side effects: : Minoxidil can cause itching, redness, and, in rare cases, unwanted facial hair growth. Rosemary oil is generally well tolerated, though some people experience mild scalp tingling. - Expectations: : Neither treatment restores a full head of hair. The best realistic outcome is a modest increase in density and a slowdown of further loss.

What’s on the Horizon Regulatory agencies have not approved rosemary oil as a medical treatment for hair loss. Ongoing Phase II trials (NCT05891234, sponsored by a biotech startup) are testing a standardized rosemary‑extract gel at 5 % concentration against minoxidil 5 % over 24 weeks. Those studies will enroll 250 participants and include objective scalp‑biopsy endpoints to clarify the molecular changes induced by the oil.

If those trials confirm the early signals, we could see a prescription‑grade rosemary product within the next 3‑5 years. Until then, patients can use high‑quality oil at their own risk, but they should discuss it with a dermatologist to rule out other causes of thinning and to coordinate it with proven therapies.

Bottom line: The viral rosemary‑vs‑minoxidil trial sparked a wave of interest because the data were real, not fabricated. The science shows that rosemary oil can modestly boost hair growth and is gentler on the scalp, but it does not outperform minoxidil in head‑to‑head comparisons. For most people, the choice will come down to tolerance, cost, and how much improvement they are hoping for. Ongoing clinical work will tell whether rosemary can move from kitchen‑shelf curiosity to an FDA‑cleared option.